 |
|
|
| |
Evaluation of Drug-Drug Interaction Between Sofosbuvir/Velpatasvir and Rifaximin in HCV-Infected Subjects with Moderate Hepatic Impairment
|
| |
| |
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy June 8-10, 2016, Washington, DC, USA
Erik Mogalian, Brian Kirby, Liyun Ni, Shu-Min Chuang, John McNally, and Anita Mathias
Gilead Sciences, Foster City, CA
AASLD: Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir and Velpatasvir (GS-5816) and HIV Antiretoviral Therapies - (12/07/15)
EASL: Drug-Drug Interaction Profile of Sofosbuvir/Velpatasvir Fixed-Dose Combination
Sofosbuvir/velpatasvir - (06/07/16)
|
| |
|
|
|
|
|
